IGFBP2 and IGFBP4 interact to activate complement pathway in diabetic kidney disease
Background Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease globally. Recent research has identified insulin-like growth factor-binding proteins 2 (IGFBP2) and 4 (IGFBP4) as potential biomarkers for DKD. Overactivation of the complement pathway in DKD remains poorly under...
Saved in:
Main Authors: | Jieling Liang, Yangxiao Huang, Daping Peng, Yali Xie, Yifei Liu, Xiuxia Lu, Junfa Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2440528 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Positive Expression of IGFBP2 as a Novel Prognostic Biomarker for Patients with Lower-Grade Gliomas
by: Yanguo Li, et al.
Published: (2025-01-01) -
Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin
by: Liman QIU, et al.
Published: (2017-08-01) -
Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies
by: Yang Yang, et al.
Published: (2025-01-01) -
Effect of diabetes mellitus on levels of insulin-like growth factors and their carrier proteins in Guerin’s carcinoma and it’s perifocal tissue in rats
by: E. M. Frantsiyants, et al.
Published: (2021-12-01) -
Complement activation in wasp venom-induced acute kidney injury
by: Rui Cheng, et al.
Published: (2024-12-01)